| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药商业(元) | 1,624,207,874.94 | 3,026,294,500.73 | 1,779,037,911.71 | 3,052,937,029.34 | 1,903,784,451.19 |
| 医药制造(元) | 1,582,977,694.61 | 3,898,464,474.92 | 2,003,344,291.27 | 4,291,459,855.29 | 2,195,653,726.98 |
| 其他(元) | - | - | 70,225,923.43 | - | 69,078,297.02 |
| 其他(含其他业务收入)(元) | 125,793,466.17 | 150,094,288.27 | - | 158,158,024.60 | - |
| 营业成本(元) | |||||
| 医药商业(元) | 1,540,886,556.49 | 2,841,953,538.21 | 1,659,497,112.68 | 2,817,026,196.35 | 1,787,722,221.49 |
| 医药制造(元) | 617,506,088.56 | 1,498,889,543.51 | 790,873,493.97 | 1,664,647,637.47 | 848,022,388.47 |
| 其他(元) | - | - | 64,798,780.10 | - | 55,316,101.24 |
| 其他(含其他业务收入)(元) | 94,089,035.24 | 96,868,083.19 | - | 114,792,445.70 | - |
| 毛利(元) | |||||
| 医药商业(元) | 83,321,318.45 | 184,340,962.52 | 119,540,799.03 | 235,910,832.99 | 116,062,229.70 |
| 医药制造(元) | 965,471,606.05 | 2,399,574,931.41 | 1,212,470,797.30 | 2,626,812,217.82 | 1,347,631,338.51 |
| 其他(元) | - | - | 5,427,143.33 | - | 13,762,195.78 |
| 其他(含其他业务收入)(元) | 31,704,430.93 | 53,226,205.08 | - | 43,365,578.90 | - |
| 毛利率(%) | |||||
| 医药商业(%) | 5.13 | 6.09 | 6.72 | 7.73 | 6.10 |
| 医药制造(%) | 60.99 | 61.55 | 60.52 | 61.21 | 61.38 |
| 其他(%) | - | - | 7.73 | - | 19.92 |
| 其他(含其他业务收入)(%) | 25.20 | 35.46 | - | 27.42 | - |
| 收入构成(%) | |||||
| 医药商业(%) | 48.73 | 42.78 | 46.18 | 40.69 | 45.67 |
| 医药制造(%) | 47.49 | 55.10 | 52.00 | 57.20 | 52.67 |
| 其他(%) | - | - | 1.82 | - | 1.66 |
| 其他(含其他业务收入)(%) | 3.77 | 2.12 | - | 2.11 | - |
| 毛利构成(%) | |||||
| 医药商业(%) | 7.71 | 6.99 | 8.94 | 8.12 | 7.86 |
| 医药制造(%) | 89.35 | 90.99 | 90.66 | 90.39 | 91.21 |
| 其他(%) | - | - | 0.41 | - | 0.93 |
| 其他(含其他业务收入)(%) | 2.93 | 2.02 | - | 1.49 | - |